Recent reductions in reimbursement for MCOT also have limited ... recording an average of over 7 days of heart monitoring. Despite US FDA approval, the Zio Patch has met slow acceptance possibly ...

the Zio Patch has the potential to replace, and be a more cost-effective monitoring solution than other event monitors and MCOT devices. For many outpatients, compliance, ease-of-use and an ...

VitalConnect raised $100 million to accelerate commercialization of its ambulatory cardiac monitoring device ... sells a disposable patch that records a patient’s heart rhythm to detect arrhythmias.